4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-038768
Chief Technology Officer sold 20,000 shares at $10.06 ($201,200)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Yan Ming Chief Technology Officer | 2022-06-21 | Sale | −20,000 | $10.06 | $201,200 | 8,084,415 | D |
| Open-market sales · 20,000 sh · avg $10.06 · $201,200 | |||||||
Loading xslF345X03/doc4.xml…